Skip to Content

Vyvanse Sales Data

Rank 27 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Vyvanse U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 27 (2) 9.39% 8.70%
Q3 2013 29 (1) 1.65% -5.31%
Q2 2013 28 (1) -6.66% -7.49%
Q1 2013 27 (1) 5.48% -2.75%
Q4 2012 28 (7) 11.92% 11.75%
Q3 2012 35 (3) -2.81% -2.60%
Q2 2012 38 (2) -3.00% -2.78%
Q1 2012 40 (3) 11.05% 4.08%
Q4 2011 43 (2) 13.05% 13.26%
Q3 2011 45 (1) 1.08% 1.51%
Q2 2011 44 (5) -1.39% -1.49%
Q1 2011 49

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
July 24, 2017Treating ADHD May Help Curb Later Drinking, Drug Problems
June 12, 2017Teens With ADHD Face a Higher Crash Risk
May 10, 2017Car Crash Rate Falls When People With ADHD Take Meds
November 15, 2016Guidelines May Have Helped Curb ADHD Diagnoses in Preschoolers
June 30, 20163 Treatments Seem to Help Combat Binge-Eating Disorder
November 15, 2010Vyvanse Approved for Adolescent ADHD
Hide